Five C-suite insiders at INSMED Inc, including the CEO and CFO, collectively sold $1.75M in open-market sales over a 7-day window. The total value is ~0.008% of the $22.7B market cap, making the cluster economically trivial and consistent with routine portfolio diversification or tax planning rather than a bearish signal.
INSM drugs
INSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 8 $94.17entry
- T+1 · 5mo ago +5.17%α +5.47% · $99.04
- T+5 · 5mo ago +3.49%α +1.38% · $97.46
- T+20 · 4mo ago +18.45%α +16.81% · $111.54
- T+60 · 3mo ago +29.03%α +25.98% · $121.51
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Five C-suite insiders at INSMED Inc, including the CEO and CFO, collectively sold $1.75M in open-market sales over a 7-day window. The total value is ~0.008% of the $22.7B market cap, making the cluster economically trivial and consistent with routine portfolio diversification or tax planning rather than a bearish signal.
Key Financial Metrics
Key Facts
- 5 insiders sold a total of $1.75M in open-market transactions from May 27 to June 3, 2026.
- CEO Lewis William sold $778K; CFO Sara Bonstein sold $246K; COO Roger Adsett sold $242K; CMO Martina Flammer sold $262K; CLO Michael Smith sold $221K.
- Total sales represent ~0.008% of INSM's $22.7B market cap, well below the 0.1% materiality threshold.
- All sales occurred at ~$102.27 per share, suggesting a coordinated window rather than opportunistic timing.
- Prior 30-day insider activity shows $3.2M in total sells, consistent with ongoing routine selling patterns.
Financial Impact
Insider sales of $1.75M represent ~0.008% of market cap, immaterial.
Risk Factors
- No material risk identified from this cluster; sales are too small to signal distress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INSM-1780690693321 |
Track record
24 reports on INSM
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +31.86% at T+60 after the Mar 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Nov 3, 202613d ago 3 Neutral 1/10 Entry $110.00 Now $122.88 +11.71% settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $111.59 Now $122.88 +10.12% settles Nov 27
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $94.04 Now $122.88 +30.67% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $95.67 Now $122.88 +28.44% settles Nov 17
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $103.83 to $112.58 Now $122.88 +18.35% ▲ +8.43% +10.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 4/10 Entry $125.08 to $120.00 Now $122.88 −1.76% ▼ −4.06% −4.19% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $126.33 to $129.41 Now $122.88 −2.73% ▲ +2.44% +4.19% vs SPY
- Aug 6, 202614w ago 8-K Bullish 8/10 Entry $132.55 to $126.68 Now $122.88 −7.30% ▼ −4.43% −5.03% vs SPY
- Jul 24, 202616w ago Institutional Cluster Neutral 4/10 Entry $106.92 to $125.77 Now $122.88 +14.93% ▲ +17.63% +14.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers